Receptos Inc (NASDAQ:RCPT) Shareholder Alert: Lawsuit Against Takeover by Celgene Corporation
An investor in NASDAQ:RCPT shares filed a lawsuit against proposed takeover of Receptos by Celgene Corporation for $232.00 per share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:RCPT stockholders by agreeing to sell Receptos Inc too cheaply via an unfair process to Celgene Corporation.
View full press release